Table 1 Correlation between PLK4 protein expression and clinicopathological characteristics of DLBCL patients.

From: Inhibition of Polo-like kinase 4 induces mitotic defects and DNA damage in diffuse large B-cell lymphoma

Variables

No. of patients

PLK4 expression

P value

Positive

Negative

Age (years)

≤60

36

27

9

0.936

>60

29

22

7

 

Gender

Male

30

23

7

0.824

Female

35

26

9

 

Ann Arbor Stage

I or II

24

17

7

0.515

III or IV

41

32

9

 

Subtype

GCB

20

14

6

0.502

Non-GCB

45

35

10

 

Serum LDH

Normal

41

31

10

0.26

Elevated

24

18

6

 

Extranodal involvement

Absent

37

26

11

0.271

Present

28

23

5

 

IPI score

0–2

30

19

11

0.037*

3–5

35

30

5

 
  1. GCB germinal center B cell-like, LDH lactate dehydrogenase, IPI International Prognostic Index.
  2. *P < 0.05.
Back to article page